RAC1 and breast cancer: For instance, in breast cancer, Rac1 activation of aldolase A and ERK signaling triggers the non-oxidative PPP, enhancing nucleotide metabolism and shielding breast cancer cells from chemotherapy-induced DNA damage, thereby inducing chemotherapy resistance[9].